���ϳԹ�

Obtaining consistent and reliable results when culturing immune cells can be challenging. Watch this webinar to discover how to obtain high yields of functional T cells, NK cells, B cells, dendritic cells, and macrophages for your research applications. The speaker, Evan Karas, also explains how to expand primary T cells without feeders or serum.

Obtaining high yields of viable engineered T cells for cell therapy research and immunotherapy development can be challenging. Lengthy and inefficient processes for cell isolation, cell culture, and gene transfer can cause delays and prevent scientists from reaching their goals. Watch as Drs. Sneha Balani and Angela Zhang discuss best practices and innovative technologies for T cell therapy research.

This webinar describes steps and considerations involved in translating research to the clinic.

CRISPR-Cas genome editing in cell culture systems is a powerful technique for disease modeling and the development of cellular therapies. Compared to work with immortalized cell lines, genome editing of stem and primary cells presents unique challenges, including issues related to efficient delivery and expression of CRISPR machinery, clonogenicity, and cytotoxicity. In this webinar, our in-house expert, Dr. Ashley Watson, discusses optimized workflows for CRISPR-Cas9 genome editing in human pluripotent stem cells and primary T cells.

Learn about human T cell isolation, activation, and expansion workflow for cell therapy

EasySep™ technology, a fast and easy immunomagnetic cell separation technology that allows you to isolate virtually any cell types from a variety of sample sources in as little as 8 minutes

Isolation of human CD4+ T cells by negative selection using EasySep™ to separate highly purified cells in as little as 8 minutes